View drug registration information details.


ItemsRegistration information
ID136
No136
Brand NameESOPRAZOLE-20
IngredientsESOMEPRAZOLE MAGNESIUM EQ.TO ESOMEPRAZOLE USP 20 MG
Dosage FormCAPSULE
Primary PackagingALU-ALU BLISTER
StorageSTORE BELOW 30 C
Shelf Life36 MONTHS
Pack SizeBOX OF 10 X 10'S
Dispensing CategoryPRESCRIPTION
ATC Classification
Pharmaceutical ClassPPI
IndicationsGASTRO-OESOPHAGEAL REFLUX DISEASE, TREATMENT OF EROSIVE REFLUX OESOPHAGITIS, LONG TERM MANAGEMENT OF PATIENTS WITH HEALED OESOPHAGITIS TO PREVENT RELAPSE, SYMPTOMATIC TREATMENT OF GASTRO-OESOPHAGEAL REFLUX DISEASE, HEALING OF GASTRIC ULCERS ASSOCIATED WITH NSAID THERAPY, PREVENTION OF GASTRIC AND DUODENAL ULCERS ASSOCIATED WITH NSAID THERAPY IN PATIENTS AT RISK, HEALING OF HELICOBACTER PYLORI ASSOCIATED DUODENAL ULCER
ContraindicationsHYPERSENSITIVITY TO ESOMEPRAZOLE, OR TO ANY EXCIPIENT FROM FORMULATION, NOT BE USED CONCOMITANTLY WITH NELFINAVIR
Side EffectsHEADACHE, ABDOMINAL PAIN, DIARRHEA, NAUSEA
Unit Price
EDL No
DescriptionPINK COLORED CAP & CLEAR TRANSPARENT BODY OF CAPSULE SIZE 2, CONTAINING WHITE PELLETS
Note
License OwnerASA LAO SOLE COMPANY LIMITED
ManufacturerIMPULSE PHARMA PVT. LTD
CountryINDIA
Import Registration NoKD/641 (FORM 25)
Import Registration Date2022-08-11
ActivityCERTIFICATE RELEASED
Applied Date2023-07-17
FDD Registration No04 I 5726/24
FDD Registration Date26/4/2024
Expiry Date25/4/2027

Back to drug list